Alpa Laboratories

What Alpa Laboratories does

Alpa Laboratories Limited is a publicly listed Indian pharmaceutical manufacturer (BSE: 532878) of finished dosage forms, headquartered in Pigdamber, Indore, Madhya Pradesh. Operating since 1967, the company produces 400+ formulations across multiple dosage forms — tablets, capsules, liquid and dry powder injections, eye and ear drops, creams/gels/ointments, veterinary boluses, and intramammary infusions — split between human pharmaceuticals (ethical, generic, and OTC) and veterinary products. Manufacturing is conducted in a single WHO-GMP and ISO 9001:2000 certified facility spanning 1.20 acres, with class 100/1,000/10,000/100,000 controlled environments, dedicated air handling units, and CTD dossier capability for regulatory submissions.

The company operates a hybrid B2B revenue model combining own-brand distribution with contract manufacturing for other Indian and multinational pharmaceutical companies. Domestically, products flow through state-level distributors to 1,000+ retail chemists, pharmacy stores, and hospitals. Internationally, the company exports to 40+ countries across South America, Central America, Africa, and Asia (including CIS markets such as Russia, Ukraine, and Kazakhstan), supported by facility inspections and product registrations from national health authorities including NAFDAC (Nigeria), MOH Sudan, MOH Sri Lanka, MOH Namibia, MOH Sierra Leone, and the Republic of Haiti. Pricing is B2B and not publicly disclosed, and marketing is limited to professional distribution channels and standard social media accounts.

For FY2026 (year ended March 2026), Alpa reported Rs 105.81 crore in sales (down 5.90% YoY) and Rs 15.01 crore in net profit (down 23.03% YoY), with Q4 FY2026 sales of Rs 31.40 crore down 21.34% YoY. The company has 11-50 employees per firmographic data, a single disclosed executive (Mahendra Singh Chawla, Wholetime Director), and an open Company Secretary and Compliance Officer position following the resignation of Ms. Yashoda Patidar effective July 26, 2026.

Name

Alpa Laboratories

Legal name

Alpa Laboratories Limited

Website

https://alpalabs.in

Company type

Public

Founded year

1967

Operating status

Operating

Headcount range

11–50 employees

Short description

Alpa Laboratories Limited is a publicly listed Indian pharmaceutical manufacturer producing 400+ generic and OTC finished dosage forms (tablets, capsules, injectables, ophthalmics, topicals, veterinary) from a WHO-GMP facility in Indore, serving 1,000+ domestic distributors and exporting to 40+ countries.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Eye, Ear & Nasal Care (HLAIADAF)

akta.pro secondary industry

Animal Health OTC Retail (Parasite Control, Basic Care) (HLAMAIAJ)

Keywords

• Generic pharmaceuticals manufacturing
• Finished dosage forms
• Pharmaceutical contract manufacturing
• Veterinary pharmaceutical formulations
• Pharmaceutical export services

Headquarters

HQ city

Indore

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Manufacturing and selling pharmaceutical finished dosage forms under own brand and for other companies. Product range includes ethical, generic, and OTC drugs for human and veterinary use.
2. Contract Manufacturing: Manufacturing pharmaceutical products for other reputed Indian and multinational pharmaceutical companies under their brands

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Alpa Laboratories manufactures pharmaceutical finished dosage forms including capsules, tablets, injections, ear and eye drops, creams, gels, and ointments. The company produces ethical, generic, and over-the-counter (OTC) drugs for both human and veterinary use under its own brand and on contract for other Indian and multinational pharmaceutical companies. Operations are conducted from a WHO-GMP and ISO 9001:2000 certified facility in Pigdamber, Indore, serving domestic Indian markets and exporting to over 40 countries.

Product overview

Alpa Laboratories is a pharmaceutical finished dosage form (FDF) manufacturer offering a diverse portfolio of generic and OTC drugs. The company operates as a pure pharmaceutical manufacturer without a platform or software product architecture. The product portfolio consists of multiple dosage forms (capsules, tablets, injections, ear/eye drops, creams/gels/ointments) organized into two main categories: Human Formulations and Veterinary Formulations. With over 400 formulations and products spanning therapeutic areas including anti-infectives, analgesics, anti-inflammatory drugs, cardiovascular drugs, anti-diabetics, nutritional supplements, psychotropic drugs, and dermatological preparations, the company serves both domestic Indian markets and international markets across South and Central America, Africa, and Asia including CIS countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Capsules
• Tablets Tablet formulations including uncoated, coated, dispersible, and bolus variants for human and veterinary use across multiple therapeutic categories.
• Injections Sterile parenteral products including liquid injections, dry powder injections, and ampule/vial formulations for human and veterinary applications.
• Ear & Eye Drops Ophthalmic and otic solutions including antibiotic, anti-inflammatory, and combination formulations for eye and ear conditions.
• Creams, Gels & Ointments Topical semi-solid formulations including antibiotic creams, anti-inflammatory gels, wound care ointments, and sterile ophthalmic ointments.
• Boluses (Veterinary) Large animal pharmaceutical boluses for veterinary use including anthelmintics, nutritional supplements, and antibiotic formulations.
• Intra-Mammary Infusions (Veterinary) Sterile intramammary infusions for veterinary use in treating mastitis and other udder conditions in lactating animals.

Named customers3 records

Segments2 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core.

• NAFDAC (National Agency for Food and Drug Administration and Control Nigeria)coreOthersRegulatory approval relationship with Nigeria's national drug regulatory authority. Products inspected and approved for export to Nigerian market.
• Ministry of Health SudancoreOthersRegulatory approval from Sudan's Ministry of Health. Manufacturing facility inspected and approved for pharmaceutical exports.
• Ministry of Health and Social Services Republic of NamibiacoreOthersRegulatory inspection and approval by Namibian health authority for pharmaceutical product registration.
• Ministry of Health Sri LankacoreOthersProduct registration and approval by Sri Lankan Ministry of Health for pharmaceutical exports.
• Republic of Haiti Ministry of HealthcoreOthersProduct registration with Haitian health authority for pharmaceutical distribution in Haiti.
• Ministry of Health Republic of Sierra LeonecoreOthersRegulatory approval from Sierra Leone health ministry after facility inspection.

Scale indicators10 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Cipla: One of India's largest generic pharmaceutical manufacturers with extensive WHO-GMP manufacturing and global export presence across Africa, Asia, and Latin America; defines the competitive landscape Alpa operates within for export dossiers.
• Granules India: Indian pharmaceutical manufacturer specializing in finished dosage forms with API backward integration; competes in similar generic formulations across domestic and emerging markets.
• Ajanta Pharma: Indian pharma manufacturer with WHO-GMP facilities and strong emerging-market export presence across Africa, Asia, and CIS; relevant scale and regulatory benchmark for Alpa's expansion ambition.
• Ipca Laboratories: Mid-to-large Indian pharma manufacturer producing generics across multiple therapeutic categories with significant export footprint; provides scale benchmark for Alpa's diversification strategy.
• Aurobindo Pharma: Major Indian generic manufacturer with broad finished dosage form production across orals, injectables, and sterile products and a dominant presence in African and CIS export markets where Alpa also competes.

Direct peers

• Lincoln Pharmaceuticals: Indian pharma manufacturer producing finished dosage forms including injectables, ointments, and ophthalmic/otic preparations with multi-country exports; comparable in scale, product breadth, and export orientation.
• Amrutanjan Health Care: Indian pharma company with a comparable footprint of OTC and ethical formulations plus OTC product registrations across multiple emerging markets; overlapping customer base in pharmacy retail.
• Unichem Laboratories: Indian generic pharmaceutical manufacturer with WHO-GMP facilities producing finished dosage forms for domestic and export markets; directly comparable in formulation breadth, regulatory orientation, and Indian stock exchange listing.
• Akums Drugs & Pharmaceuticals: India-based contract manufacturer of finished dosage forms producing for both own-brand and MNC clients across tablets, capsules, injectables, and sterile products; Alpa's contract manufacturing model is the closest direct analog.
• Medicamen Biotech: Small-cap Indian listed pharma manufacturer producing generic finished dosage forms including injectables and orals for domestic and emerging-market export; similar scale, listing status, and product mix.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/alpa-laboratories-limited

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alpa Laboratories